Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...
Please provide your email address to receive an email when new articles are posted on . The Stentrode brain-computer interface offers a non-invasive, nonsurgical solution for paralysis. Additional ...
Apple is getting into the brain-computer interface (BCI) business, reveals a press release from New York-based startup Synchron. The idea is to enable people with limited mobility to use iPhones, ...
The brain-computer interface developer Synchron has shown that its minimally invasive device can help connect a patient with an iPad, allowing them to control the device entirely by thought using ...
Apple is planning to allow users to natively control iPhones, iPads, and other devices using brain signals later this year, The Wall Street Journal reports. The initiative involves a partnership with ...
Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results